Phase ii trial of a metronomic schedule of docetaxel and capecitabine with concurrent celecoxib in patients with prior anthracycline exposure for metastatic breast cancer - Young, S D; Lafrenie, R M; Clemons, M J (Curr Oncol, 2012)